Solifenacin clinical trials
Also written Vesicare and YM905.
How each study uses solifenacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the solifenacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Nov 2004 · VESICARE · NDA 021518 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Brand
- Vesicare
- 48
Studies by the year they started
99 studies that test it; most in 2010 (13)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 6 |
| 2010 | 13 |
| 2011 | 7 |
| 2012 | 12 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 49 · Other 51
Astellas Pharma Inc (26) · Astellas Pharma Europe B.V. (14) · Mansoura University (4) · Far Eastern Memorial Hospital (3) · Loyola University (3) · National Taiwan University Hospital (3) · University of Aarhus (2) · University of South Florida (2)
Often tested with
Tested in the same studies.
Mirabegron (19) · Tamsulosin (15) · Tolterodine (3) · Tadalafil (2) · EC905 (2) · Oxybutynin (2) · Estrogens (2) · Vitamin D (1)
Related medicines
As reviewed, each with the page that says it.
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test solifenacin, phase 3 first.
- Oct 2027Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)Phase 3 · University of Aarhus
- Apr 2027Melatonin and Solifenacin for Double-J Ureteral Stent SymptomsPhase 2 · Beni-Suef University
- Jul 2027Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsPhase 2 · University of Arkansas
Studies
Open first, then newest update. How each study uses solifenacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 100
- Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)RecruitingPhase 3University of AarhusNCT06551246Written as SolifenacinHow we know
- Melatonin and Solifenacin for Double-J Ureteral Stent SymptomsRecruitingPhase 2Beni-Suef UniversityNCT07617922Written as SolifenacinHow we know
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsRecruitingPhase 2University of ArkansasNCT01530373Written as solifenacinHow we know
- Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in WomenNot yet recruitingPhase 3Mansoura UniversityNCT07429734Written as solifenacin combined with gabapentinHow we know
- Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related SymptomsRecruitingPhase 3Bir HospitalNCT06803030Written as Solifenacin Succinate 5 mgHow we know
- The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingPhase 3Far Eastern Memorial HospitalNCT07114640Written as Solifenacin 5 mgHow we know
- Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive BladderRecruitingPhase 4Mackay Memorial HospitalNCT06479720Written as Solifenacin with vaginal estrogen creamHow we know
- Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor OveractivityRecruitingPhase 4Mackay Memorial HospitalNCT06197295Written as Solifenacin with vaginal estrogen creamHow we know
- Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinRecruitingPhase 3Far Eastern Memorial HospitalNCT04023253Written as SolifenacinHow we know
- Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)Active, not recruitingPhase 4University of AarhusNCT06465576Written as SolifenacinHow we know
- Double j Stent Related SymptomsCompletedEarly Phase 1Kafrelsheikh UniversityNCT07447518Written as SolfenacinHow we know
- Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic BiomarkerCompletedNot applicableXing LiuNCT06489951Written as SolifenacinHow we know
- Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.CompletedPhase 4Liaquat National Hospital & Medical CollegeNCT07114848Written as solifenacinHow we know
- Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.CompletedPhase 4Astellas Pharma IncNCT01093534Written as solifenacinHow we know
- Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedPhase 3Astellas Pharma Europe B.V.NCT01021332Written as tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)How we know
- Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedPhase 3Astellas Pharma Europe B.V.NCT01018511Written as tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)How we know
- A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical ProstatectomyCompletedPhase 4Astellas Pharma IncNCT01371994Written as solifenacin succinateHow we know
- A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor OveractivityCompletedPhase 3Astellas Pharma Europe B.V.NCT01565694Written as Solifenacin succinateHow we know
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedPhase 4Astellas Pharma IncNCT00629642Written as Solifenacin SuccinateHow we know
- A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076CompletedPhase 3Astellas Pharma Europe B.V.NCT01655069Written as Solifenacin succinate suspensionHow we know
See all 100 studies that test solifenacin →
Given beside what is tested · 5 — solifenacin is usual care or a partner of the new treatment
- Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.CompletedPhase 4Astellas Pharma IncNCT02294396Written as Solifenacin tabletHow we know
- Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OABStatus unknownPhase 4Mansoura UniversityNCT05494567Written as solifenacin 10 mgHow we know
- Therapy of the Overactive Bladder SyndromeCompletedPhase 4Cantonal Hospital, FrauenfeldNCT01314781Written as solifenacinHow we know
- Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedPhase 4Astellas Pharma Taiwan, Inc.NCT02715024Written as SolifenacinHow we know
- Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal WomenCompletedPhase 4Peking Union Medical College HospitalNCT01833663Written as Solifenacin Succinate TabletsHow we know
As the comparator · 22 — what is tested is compared with solifenacin
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetRecruitingNot applicableChildren's Hospital of Chongqing Medical UniversityNCT06201013Written as Solifenacin SuccinateHow we know
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruitingPhase 4Mansoura UniversityNCT07473310Written as Oral Solifenacin succinate 5 mgHow we know
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National StudyRecruitingPhase 4Mansoura UniversityNCT07416968Written as Solifenacin 5mgHow we know
- Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive BladderRecruitingNot applicableYin PingNCT05798403Written as Solifenacin Succinate TabletsHow we know
- Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in FemalesCompletedNot applicableAin Shams UniversityNCT07312955Written as SolifenacinHow we know
- A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.CompletedPhase 3Astellas Pharma Europe Ltd.NCT01638000Written as Solifenacin succinateHow we know
- A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderCompletedPhase 3Dong-A ST Co., Ltd.NCT05282069Written as Solifenacin 5mgHow we know
- Study of ONO-8577 in Patients With Overactive BladderCompletedPhase 2Ono Pharmaceutical Co. LtdNCT03106623Written as solifenacin succinate + mirabegronHow we know
- Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in ChildrenCompletedNot applicableXing LiuNCT05709990Written as Solifenacin Succinate 5 MG Oral Tablet [Vesicare]How we know
- Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary IncontinenceStatus unknownNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT03787654Written as SolifenacinHow we know
- Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive BladderStatus unknownPhase 4China Medical University HospitalNCT04909255Written as oxybutynin, tolterodine, solifenacinHow we know
- A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive BladderCompletedPhase 2Dong-A ST Co., Ltd.NCT03566134Written as Solifenacin 5mgHow we know
- Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary IncontinenceCompletedNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT02047032Written as solifenacinHow we know
- A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary IncontinenceCompletedPhase 3AllerganNCT01767519Written as solifenacinHow we know
- Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder SyndromeStatus unknownPhase 4Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaNCT03468465Written as Solifenacin SuccinateHow we know
- Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive BladderCompletedPhase 4Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT03558919Written as Solifenacin Succinate 5 MGHow we know
- Anticholinergic vs. Botox Comparison StudyCompletedPhase 3NICHD Pelvic Floor Disorders NetworkNCT01166438Written as Solifenacin 5mgHow we know
- Efficacy and Safety of Gabapentin in Treating Overactive BladderCompletedPhase 2/3Michael E. ChuaNCT01486706Written as Solifenacin SuccinateHow we know
- Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy StudyStatus unknownNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT02452879Written as Solifenacin SuccinateHow we know
- Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or VasaStatus unknownPhase 1/2Klinikum der Universität KölnNCT01737918Written as solifenacinHow we know
Showing 20 of 22.
Codes
What other systems call solifenacin · ClinicalTrials.gg INT006592
- MeSH (NLM) D000069464Solifenacin SuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A8910SQJ1USOLIFENACINConfirmed FDA, NLM, Wikidata
- RxNorm 322167One source FDA
- Wikidata Q59575279solifenacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75284SolifenacinOne source FDA
- DrugBank DB01591One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069464 | Solifenacin Succinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A8910SQJ1U | SOLIFENACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 322167 | — | One source FDA |
| Wikidata | Q59575279 | solifenacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75284 | Solifenacin | One source FDA |
| DrugBank | DB01591 | — | One source Wikidata |
Also registered as solifenacin succinate (UNII KKA5DLD701 · RxNorm 476588).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.